Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $425.5M | $607.0M | $716.3M | $835.4M | $920.7M | $1,092.4M | $1,243.1M | $1,368.5M | $1,514.5M | $1,555.0M | $1,678.9M | $1,838.7M | $2,066.7M | $2,340.2M | $2,606.6M | $2,957.0M | $3,196.8M | $3,578.1M | $4,223.0M | $4,685.3M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, ResMed Inc.'s last 12-month Revenue is $4,926.8M, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, ResMed Inc.'s Revenue growth was 12.9%. The average annual Revenue growth rates for ResMed Inc. have been 15.5% over the past three years, 12.1% over the past five years.
Over the last year, ResMed Inc.'s Revenue growth was 12.9%, which is higher than industry growth of 0.0%. It indicates that ResMed Inc.'s Revenue growth is Good.